Top in allergy/asthma: Anaphylaxis tied to lipid-lowering drugs; interactive allergen guide
Healio spoke with an expert about their study of U.S. and Canadian patients who had anaphylaxis to insect stings between 2010 and 2023, which revealed that those taking lipid-lowering medications experienced more severe reactions.
“Our findings are significant because they uncover a previously unrecognized risk factor for severe anaphylaxis,” Kaylee Sohng, a PGY3 internal medicine resident at the University of Toronto, told Healio. “Given the widespread use of lipid-lowering medications, this discovery carries important implications for clinical practice, particularly for individuals at heightened risk [for] severe allergic reactions.”
It was the top story in allergy/asthma last week.
Another top story highlighted EveryBite’s SmartMenu platform, an interactive nutrition and allergen guide that allows people with food allergies to personalize their dining experience and provides customer insights to restaurants.
Read these and more top stories in allergy/asthma below:
Q&A: Lipid-lowering drugs linked to increased risk for severe insect sting anaphylaxis
Patients who were taking lipid-lowering medications experienced more severe anaphylaxis after insect stings, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting. Read more.
Digital platform sorts online restaurant menus by allergic ingredients
Dining out can be scary for the 33 million people in the United States with a food allergy. Even when restaurants list allergic ingredients in their menus, the information may be out of date or hard to find. Read more.
Q&A: Pain management possible for patients with drug allergies
Patients who experience musculoskeletal pain have many pharmaceutical options for relief — unless they also suffer from allergies to these medications. Read more.
Inaccurate aspirin allergy labels increase odds for poor stroke outcomes
Patients with stroke and inaccurate NSAID allergy labels had poorer outcomes, including major adverse cardiovascular events, peripheral vascular disease and death, according to a study published in Stroke. Read more.
Peanut oral immunotherapy desensitizes children with higher allergy thresholds
Increasingly larger doses of store-bought peanut butter enabled desensitization to peanut protein allergy in children initially able to ingest more than half a peanut, study results published in NEJM Evidence suggested.. Read more.